Elevate Credit is part of the financial services sector and trades as part of the credit services industry. The company CEO is Kenneth E. Rees. Elevate Credit Inc provides technology-driven, progressive online credit solutions to non-prime consumers. It uses advanced technology and proprietary risk analytics to provide convenient and responsible financial options to its customers.

Previous Intraday Performance:

The ELVT shares had a previous change of 5.83% which opened at 4.10 and closed at 4.36. It moved to an intraday high of 4.39 and a low of 4.10.

Business Wire:  Elevate Nominated for Diversity & Inclusion Award from the Council for Inclusion in Financial Services (CIFS)

Historical Performance:

Over the last five trading days, ELVT shares returned 1.63% and in the past 30 trading days it returned -0.23%. Over three months, it changed 2.35%. In one year it has changed -47.78% and within that year its 52 week high was 11.27 and its 52 week low was 3.71. ELVT stock is 17.52% above its 52 week low.

Our calculations result in a 200 day moving average of 5.39 and a 50 day moving average of 4.49. Right now, ELVT stock is trading -19.18% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

Business Wire:  Elevate Nominated for Diversity & Inclusion Award from the Council for Inclusion in Financial Services (CIFS)


The company has a market cap of $189.2m with 43.4m shares outstanding and a float of 42.4m shares. Trading volume was 130,649 shares and has experienced an average volume of 130,748 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for Elevate Credit was 0.28 which ended on 31st of December 2018, which according to the previous close, that is a PE of 15.57. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.21. The trailing twelve month EPS reported is 0.40 (trailing twelve month diluted EPS is 0.36).

Below was the last reported quarterly diluted earnings per share:

1stQtr 2019Reported 04-29-2019: 0.30
4thQtr 2018Reported 02-11-2019: 0.09
3rdQtr 2018Reported 10-29-2018: -0.10
2ndQtr 2018Reported 07-30-2018: 0.07
1stQtr 2018 0.22

Base on our calculations, the intrinsic value per share is 6.69, which means it might be undervalued and has a margin of safety of 34.84%.

The long-term trend of the EPS is an important number as it indicates the present value of Elevate Credit; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been 6.20% over the last twelve months.

Indicators Also to Watch:

Based on the latest filings, there is 59.00% of institutional ownership. Short-interest was 671,198, which was 1.55% of shares outstanding. The short-interest ratio or days-to-cover ratio was 6.95. This stock has some short interest, but it might be normal and no need to worry if long the position.

The beta was calculated to be 1.55.

SeekingAlpha:  Citius Pharma continues Mino-Lok-stoked rally, up 13%

Fundamental Numbers:

Based on last reported financials, the company’s return on assets is 2.29%, profit margin is 2.10%, price-to-sales is 0.23 and price-to-book is 1.34.

Company Score Card:

Results are out of six:
 5  : Growth Expectations Result
 3  : Financial Safety Result
 5  : Past Performance Result
 3  : Valuation Result
 0  : Dividend Safety Result
 4  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here